Children still prescribed postop codeine despite warningsA new study reveals that too many children are still given codeine or codeine-containing medications after surgery.
FDA takes tough stance on kids’ opioid cold medsFDA is taking its toughest stance yet on opioid-containing cough and cold medications for children.
FDA: Opioid Cold Meds Not Safe for Kids
FDA: Opioid Cold Meds Not Safe for KidsThe agency’s ruling also added an additional Boxed Warning.
Promoting Drug Safety During Breastfeeding
Promoting Drug Safety During BreastfeedingPharmacists can help women who breastfeed by identifying the safest drugs and dosage schedules to minimize exposure.
FDA eyes opioids in kids' medicines
FDA eyes opioids in kids' medicinesAn FDA committee will review prescription opioid products containing hydrocodone or codeine to treat coughs in children.
DEA wants to slash opioid productionThe Drug Enforcement Administration wants to slash the production of opioid painkillers by 20% in 2018.
FDA: Limit codeine and tramadol use in kidsFDA said this week that it is restricting the use of codeine and tramadol medicines in children. The drug’s labels will now include a contraindication that codeine should not be used to treat pain or cough, and that tramadol should not be used to treat pain, in children younger than 12 years.
FDA Issues New Label Change for Codeine and Tramadol
FDA Issues New Label Change for Codeine and TramadolDecades of research has led to a flurry of new warnings.
AAP recommends against codeine useThe American Academy of Pediatrics (AAP) is no longer recommending codeine use in children because it can be either ineffective or too effective—leading to respiratory depression and even death.
FDA approves cough, cold drugFDA has approved codeine polistirex and chlorpheniramine polistirex (Tuzistra XR, Vernalis plc and Tris Pharma) extended-release oral suspension, CIII (DEA Schedule III).